|
ING2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.074000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.448000E-02 |
| Normal-vs-Stage2 |
5.926400E-02 |
| Normal-vs-Stage3 |
2.628000E-02 |
| Normal-vs-Stage4 |
4.054400E-02 |
| Stage1-vs-Stage2 |
5.436800E-01 |
| Stage1-vs-Stage3 |
2.772000E-01 |
| Stage1-vs-Stage4 |
3.938000E-01 |
| Stage2-vs-Stage3 |
7.510600E-01 |
| Stage2-vs-Stage4 |
6.760800E-01 |
| Stage3-vs-Stage4 |
8.909800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.013830E-01 |
| Normal-vs-AfricanAmerican |
4.972200E-02 |
| Normal-vs-Asian |
7.820000E-02 |
| Caucasian-vs-AfricanAmerican |
4.089600E-01 |
| Caucasian-vs-Asian |
3.671000E-01 |
| AfricanAmerican-vs-Asian |
5.635000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.714400E-02 |
| Normal-vs-Female |
2.425400E-01 |
| Male-vs-Female |
3.493000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.006200E-02 |
| Normal-vs-Extreme_Weight |
7.488300E-02 |
| Normal-vs-Obese |
1.800050E-01 |
| Normal-vs-Extreme_Obese |
9.859800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.829600E-01 |
| Normal_Weight-vs-Obese |
5.590000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.044000E-01 |
| Extreme_Weight-vs-Obese |
8.158000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.489400E-01 |
| Obese-vs-Extreme_Obese |
4.064000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.255400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.013440E-01 |
| Normal-vs-Age(61-80Yrs) |
8.988000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.267400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.291800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.149000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.846600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.437600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.571800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.811800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.826000E-01 |
| Normal-VS-Type2 PRCC |
3.179900E-03 |
| Normal-VS-KIRP CIMP |
6.922200E-01 |
| Normal-VS-Unclassified PRCC |
4.152200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.317870E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.624000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.033600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.441800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.491200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.015370E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.538500E-03 |
| Normal-vs-N1 |
3.360800E-01 |
| Normal-vs-N2 |
3.628000E-02 |
| N0-vs-N1 |
1.418990E-01 |
| N0-vs-N2 |
5.868000E-01 |
| N1-vs-N2 |
2.626400E-01 |
|
|
